Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...Consulting Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
Contract Type FiledOctober 4th, 2024 Company Industry JurisdictionWHEREAS the Company desires to obtain the benefit of the services of the Consultant, and the Consultant desires to render such services on the terms and conditions set forth;
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...Consulting Agreement • May 29th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
Contract Type FiledMay 29th, 2024 Company Industry JurisdictionWHEREAS the Company desires to obtain the benefit of the services of the Consultant, and the Consultant desires to render such services on the terms and conditions set forth;